Skip to main content

and
  1. Article

    Open Access

    Construction of lncRNA- and circRNA-associated ceRNA networks in the prostatic urethra of rats after simulating transurethral laser prostatectomy (TULP)

    Non-coding RNA appears to be involved in wound repair. Competing endogenous RNA (ceRNA) appears to be an important post-transcriptional mechanism, it means that long noncoding RNA (lncRNA) or circular RNA (cir...

    **aoHu Tang, ZhiYan Liu, Hao Liu, Heng Zhang in Molecular and Cellular Biochemistry (2024)

  2. Article

    Open Access

    C-type lectin-like receptor 2: roles and drug target

    C-type lectin-like receptor-2 (CLEC-2) is a member of the C-type lectin superfamily of cell surface receptors. The first confirmed endogenous and exogenous ligands of CLEC-2 are podoplanin and rhodocytin, resp...

    Lan Sun, Zhe Wang, Zhiyan Liu, Guangyan Mu, Yimin Cui, Qian **ang in Thrombosis Journal (2024)

  3. Article

    Open Access

    Optimal anti-platelet therapy for older patients with acute coronary syndrome: a network meta-analysis of randomized trials comprising 59,284 older patients

    The aim of this study was to identify the optimal anti-platelet therapy in older acute coronary syndrome (ACS) patients with a mean age ≥ 60 years by comparing the efficacy and safety of different anti-platele...

    Shuang Zhou, Wenhui Li, Qian **ang, Zhe Wang in Journal of Thrombosis and Thrombolysis (2024)

  4. Article

    Open Access

    Comparative RNA-sequencing analysis of the prostate in a mouse model of benign prostatic hyperplasia with bladder outlet obstruction

    In ageing men, benign prostatic hyperplasia (BPH) is a chronic disease that leads to progressive lower urinary tract symptoms (LUTS) caused by obstruction of the bladder outlet (BOO). Patients with LUTS (such ...

    **aohu Tang, Zhiyan Liu, **gwen Ren, Ying Cao in Molecular and Cellular Biochemistry (2023)

  5. No Access

    Article

    Candidate Gene of NOS3, MMP3, AGT, and AGT1R and Pathway Analyses for Platelet Reactivity and Clinical Outcomes of Repeat Revascularization After First PCI in Chinese Patients

    Major disadvantages of the percutaneous coronary intervention (PCI) are the high occurrence of repeat revascularization due to restenosis and disease progression. The current study aimed to identify indicators...

    Shuang Zhou, Zhe Wang, Zhiyan Liu, Guangyan Mu in Cardiovascular Drugs and Therapy (2023)

  6. Article

    Open Access

    Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis

    Studies show inconsistent results regarding the impact of CYP2C19 genotype on the pharmacodynamics (PD) and clinical outcomes of ticagrelor. With the implementation of genotype-guided individualized antiplatelet ...

    Qiufen **e, Qian **ang, Zhiyan Liu, Guangyan Mu in BMC Cardiovascular Disorders (2022)

  7. No Access

    Article

    Target Drug-Calibrated Anti-Xa Activity Assays and Expected Peak–Trough Levels in an Asian Population: A Multicenter Study

    For patients taking factor Xa (FXa) inhibitors who have life-threatening bleeding, emergency surgery, drug interactions, etc., a rapid and precise assay is needed to monitor for potential medication failure, t...

    Zhiyan Liu, Qiufen **e, Hanxu Zhang in American Journal of Cardiovascular Drugs (2021)

  8. No Access

    Article

    Comparison of the Safety and Efficacy of Direct Oral Anticoagulants and Warfarin in Atrial Fibrillation or Venous Thromboembolism in Patients with Renal Impairment: Systematic Review, Meta-Analysis and Network Meta-Analysis.

    Due to the high risk of ischemic and arterial or venous bleeding events in atrial fibrillation (AF) or venous thromboembolism (VTE) patients with renal impairment (RI), selection of appropriate anticoagulant r...

    Zhe Wang, Qian **ang, Kun Hu, **aodan Zhang in American Journal of Cardiovascular Drugs (2021)

  9. No Access

    Article

    Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients at High Cardiovascular Risk: An Updated Systematic Review and Meta-Analysis of 32 Randomized Controlled Trials

    Proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies are powerful lipid-lowering drugs which have been shown to improve clinical endpoints in patients with hypercholesterolemia. However,...

    Guangyan Mu, Qian **ang, Shuang Zhou, Zhiyan Liu, Litong Qi in Advances in Therapy (2020)